Skip to main content
SpringerLink
Log in

Cytotoxic T-Lymphocyte Responses Elicited to Wilms' Tumor Gene WT1 Product by DNA Vaccination

  • Published:
Journal of Clinical Immunology Aims and scope Submit manuscript

Abstract

We recently have reported that Wilms' tumor gene WT1 is highly expressed not only in leukemias but also in various types of solid tumors and that WT1 protein is a novel tumor antigen against which cytotoxic T lymphocytes (CTLs) can be elicited by immunization with 9-mer WT1 peptides capable of binding to major histocompatibility complex (MHC) class I molecules. In the present study, plasmid DNA encoding murine full-length WT1 protein was injected intramuscularly into C57BL/6 mice. The mice vaccinated with the WT1 plasmid DNA elicited CTLs against the WT1 protein, and the CTLs specifically killed WT1-expressing tumor cells in a MHC class I-restricted manner. Furthermore, the vaccinated mice rejected the challenges of WT1-expressing tumor cells and survived with no signs of autoimmunity caused by the CTLs. These results demonstrated that vaccination with the WT1 plasmid DNA can elicit CTL responses specific for the WT1 protein, resulting in the acquisition of rejection activity against challenges of WT1-expressing tumor cells. This WT1 DNA vaccination may find clinical application for various types of solid tumors as well as leukemias.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

REFERENCES

  1. Call KM, Glaser T, Ito CY, Buckler AJ, Pelletier J, Haber DA, Rose EA, Kral A, Yeger H, Lewis WH, Jones C, Housman DE: Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms' tumor locus. Cell 60:509-520, 1990

    Google Scholar 

  2. Gessler M, Poustka A, Cavenee W, Nevel RL, Orkin SH, Bruns GAP: Homozygous deletion in Wilms tumours of a zinc-finger gene identified by chromosome jumping. Nature 343:774-778, 1990

    Google Scholar 

  3. Menke AL, Van der Eb AJ, Jochemsen AG: The Wilms' Tumor 1 gene: Oncogene or tumor suppressor gene? Int Rev Cytol 181: 151-212, 1998

    Google Scholar 

  4. Gjertsen MK, Bjorheim J, Saeterdal I, Myklebust J, Gaudemack G: Cytotoxic CD41 and CD81 T lymphocytes, generated by mutant p21-ras (12 Val) peptide vaccination of a patient, recognize 12 Val-dependent nested epitopes present within the vaccine peptide and kill autologous tumour cells carrying this mutation. Int J Cancer 72:784-790, 1997

    Google Scholar 

  5. Theobald M, Biggs J, Dittmer D, Levine AJ, Sherman LA: Targeting p53 as a general tumor antigen. Proc Natl Acad Sci USA 92:11993-11997, 1995

    Google Scholar 

  6. Traversari C, Van der Bruggen P, Luescher IF, Lurquin C, Chomez P, Van Pel A, De Plaen E, Amar-Costesec A, Boon T: A nonapeptide encoded by human gene MAGE-1 is recognized on HLA-A1 by cytolytic T lymphocytes directed against tumor antigen MZ2-E. J Exp Med 176:1453-1457, 1992

    Google Scholar 

  7. Gaugler B, Van den Eynde B, Van der Bruggen P, Romero P, Gaforio JJ, De Plaen E, Lethe B, Brasseur F, Boon T: Human gene MAGE-3 codes for an antigen recognized on a melanoma by autologous cytolytic T lymphocytes. J Exp Med 179:921-930, 1994

    Google Scholar 

  8. Topalian SL, Gonzales MI, Parkhurst M, Li YF, Southwood S, Sette A, Rosenberg SA, Robbins PF: Melanoma-specific CD41 T cells recognize nonmutated HLA-DR-restricted tyrosinase epitopes. J Exp Med 183:1965-1971, 1996

    Google Scholar 

  9. Fisk B, Blevins TL, Wharton JT, Ioannides CG: Identification of an immunodominant peptide of HER-2/neu protooncogene recognized by ovarian tumor-specific cytotoxic T lymphocyte lines. J Exp Med 181:2109-2117, 1995

    Google Scholar 

  10. Ressing ME, Sette A, Brandt RMP, Ruppert J, Wentworth PA, Hartman M, Oseroff C, Grey HM, Melief CJM, Kast WM: Human CTL epitopes encoded by human papilloma virus type 16 E6 and E7 identified through in vivo and in vitro immunogenicity studies of HLA-A*0201-binding peptides. J Immunol 154:5934-5943, 1995

    Google Scholar 

  11. Miwa H, Beran M, Saunders GF: Expression of the Wilms' tumor gene (WT1) in human leukemias. Leukemia 6:405-409, 1992

    Google Scholar 

  12. Miyagi T, Ahuja H, Kubota T, Kubonishi I, Koeffler HP, Miyoshi I: Expression of the candidate Wilms tumor gene, WT1, in human leukemia cells. Leukemia 7:970-977, 1993

    Google Scholar 

  13. Inoue K, Sugiyama H, Ogawa H, Nakagawa M, Yamagami T, Miwa H, Kita K, Hiraoka A, Masaoka T, Nasu K, Kyo T, Dohy H, Nakauchi H, Ishidate T, Akiyama T, Kishimoto T: WT1 as a new prognostic factor and a new marker for the detection of minimal residual disease in acute leukemia. Blood 84:3071-3079, 1994

    Google Scholar 

  14. Brieger J, Weidmann E, Fenchel K, Mitrou PS, Hoelzer D, Bergmann L: The expression of the Wilms' tumor gene in acute myelocytic leukemias as a possible marker for leukemic blast cells. Leukemia 8:2138-2143, 1994

    Google Scholar 

  15. Menssen HD, Renkl HJ, Rodeck U, Maurer J, Notter M, Schwarz S, Reinhardt R, Thiel E: Presence of Wilms' tumor gene (WT1) transcripts and the WT1 nuclear protein in the majority of human acute leukemias. Leukemia 9:1060-1067, 1995

    Google Scholar 

  16. Inoue K, Ogawa H, Sonoda Y, Kimura T, Sakabe H, Oka Y, Miyake S, Tamaki H, Oji Y, Yamagami T, Tatekawa T, Soma T, Kishimoto T, Sugiyama H: Aberrant overexpression of the Wilms' tumor gene (WT1) in human leukemia. Blood 89:1405-1412, 1997

    Google Scholar 

  17. Oji Y, Ogawa H, Tamaki H, Oka Y, Tsuboi A, Kim EH, Soma T, Tatekawa T, Kawakami M, Asada M, Kishimoto T, Sugiyama H: Expression of the Wilms' tumor gene WT1 in solid tumors and its involvement in tumor cell growth. Jpn J Cancer Res 90:194-204, 1999

    Google Scholar 

  18. Yamagami T, Sugiyama H, Inoue K, Ogawa H, Tatekawa T, Hirata M, Kudoh T, Akiyama T, Murakami A, Maekawa T, Kishimoto T: Growth inhibition of human leukemic cells by WT1 (Wilms tumor gene) antisense oligonucleotides: Implications for the involvement of WT1 in leukemogenesis. Blood 87:2878-2884, 1996

    Google Scholar 

  19. Inoue K, Takami H, Ogawa H, Oka Y, Soma T, Tatekawa T, Oji Y, Tsuboi A, Kim EH, Kawakami M, Akiyama T, Kishimoto T, Sugiyama H: Wilms' tumor gene (WT1) competes with differentiation-inducing signal in hematopoietic progenitor cells. Blood 91:2969-2976, 1998

    Google Scholar 

  20. Tsuboi A, Oka Y, Ogawa H, Elisseeva OA, Tamaki H, Oji Y, Kim EH, Soma T, Tatekawa T, Kawakami M, Kishimoto T, Sugiyama H: Constitutive expression of the Wilms' tumor gene WT1 inhibits the differentiation of myeloid progenitor cells but promotes their proliferation in response to granulocyte-colony stimulating factor (G-CSF). Leuk Res 23:499-505, 1999

    Google Scholar 

  21. Oka Y, Elisseeva OA, Tsuboi A, Ogawa H, Tamaki H, Li H, Oji Y, Kim EH, Soma T, Asada M, Ueda K, Maruya E, Saji H, Kishimoto T, Udaka K, Sugiyama H: Human cytotoxic T lymphocyte responses specific for peptides of wild-type Wilms' tumor gene WT1 product. Immunogenetics 51:99-107, 2000

    Google Scholar 

  22. Wolff JA, Malone RW, Williams P, Chong W, Acsadi G, Jani A, Felgner PL: Direct gene transfer into mouse muscle in vivo. Science 247:1465-1468, 1990

    Google Scholar 

  23. Sato Y, Roman M, Tighe H, Lee D, Corr M, Nguyen MD, Silverman GJ, Lotz M, Carson DA, Raz E: Immunostimulatory DNA sequences necessary for effective intradermal gene immunization. Science 273:352-354, 1996

    Google Scholar 

  24. Ulmer JB, Donnelly JJ, Parker SE, Rhodes GH, Felgner PL, Dwarki VJ, Gromkowski SH, Deck RR, DeWitt CM, Friedman A: Heterologous protection against influenza by injection of DNA encoding a viral protein. Science 259:1745-1749, 1993

    Google Scholar 

  25. Irvine KR, Rao JB, Rosenberg SA, Restito NP: Cytokine enhancement of DNA immunization leads to effective treatment of established pulmonary metastases. J Immunol 156:238-245, 1996

    Google Scholar 

  26. Doola DL, Sedegah M, Hedstrom RC, Hobart P, Charoenvit Y, Hoffman SL: Circumventing genetic restriction of protection against malaria with multigene DNA immunization: CD81 cell-, interferon gamma-, and nitricoxide-dependent immunity. J Exp Med 183:1739-1746, 1996

    Google Scholar 

  27. Ulmer JB, Sadoff JC, Liu MA: DNA vaccines. Curr Opin Immunol 8:531-536, 1996

    Google Scholar 

  28. Buckler AJ, Pelletier J, Haber DA, Glaser T, Housman DE: Isolation, characterization, and expression of the murine Wilms' tumor gene (WT1) during kidney development. Mol Cell Biol 11:1707-1712, 1991

    Google Scholar 

  29. Park S, Schalling M, Bernard A, Maheswaran S, Shipley GC, Roberts D, Fletcher J, Shipman R, Rheinwald J, Demetri G, Griffin J, Minden M, Housman DE, Haber DA: The Wilms tumor gene WT1 is expressed in murine mesoderm-derived tissues and mutated in a human mesothelioma. Nature Genet 4:415-420, 1993

    Google Scholar 

  30. Davies R, Moore A, Schedl A, Bratt E, Miyahawa K, Ladomery M, Miles C, Menke A, van Heyningen V, Hastie N: Multiple roles for the Wilms' tumor suppressor, WT1. Cancer Res 59 (7 suppl): 1747s-1750s; discussion 1751s, 1999

    Google Scholar 

  31. Urban JL, Schreiber H: Tumor antigens. Annu Rev Immunol 10:617-644, 1992

    Google Scholar 

  32. Van den Eynde B, Van der Bruggen P: T cell defined tumor antigen. Curr Opin Immunol 9:684-693, 1997

    Google Scholar 

  33. Yotnda P, Firat H, Garcia-Pns F, Garcia G, Gourru G, Vemant JP, Leonnier A, Leblond V, Langlade-Demoyen P: Cytotoxic T cell response against chimeric p210 BCR-ABL protein in patients with chronic myelogenous leukemia. J Clin Invest 101:2290-2296, 1998

    Google Scholar 

  34. Yotnda P, Garcia F, Peuchmaur M, Grandchamp B, Duval M, Lemonnier F, Vilmer E, Langlade-Demoyen P: Cytotoxic T cell response against the chimeric ETV6-AML1 childhood acute lymphoblastic leukemia. J Clin Invest 102:455-462, 1998

    Google Scholar 

  35. Wen Y-J, Lim SH: T cell recognize the VH complementaritydetermining region 3 of the idiotypic protein of B cell non-Hodgkin's lymphoma. Eur J Immunol 27:1043-1047, 1997

    Google Scholar 

  36. Lai WC, Bennett M: DNA vaccines. Crit Rev Immunol 18:449-484, 1998

    Google Scholar 

  37. Benton PA, Kennedy RC: DNA vaccine strategies for the treatment of cancer. Curr Top Microbiol Immunol 226:1-20, 1998

    Google Scholar 

  38. Corr M, Lee DJ, Carson DA, Tighe H: Gene vaccination with naked plasmid DNA: Mechanism of CTL priming. J Exp Med 18:1555-1560, 1996

    Google Scholar 

  39. Conry RM, Lobuglio AF, Kantor J, Schlom J, Loechel F, Moore SE, Sumerel LA, Barlow DL, Abrams S, Curiel DT: Immune response to a carcinoembryonic antigen polynucleotide vaccine. Cancer Res 54:1164-1168, 1994

    Google Scholar 

  40. Keene JA, Forman J: Helper activity is required for the in vivo generation of cytotoxic T lymphocytes. J Exp Med 155:768-782, 1982

    Google Scholar 

  41. Mitchison NA, O'Malley C: Three-cell-type clusters of T cells with antigen-presenting cells best explain the epitope linkage and noncognate requirements of the in vivo cytolytic response. Eur J Immunol 17:1579-1583, 1987

    Google Scholar 

  42. Bennett SR, Carbone FR, Karamalis F, Miller JF, Heath WR: Induction of a CD8+ cytotoxic T lymphocyte response by crosspriming requires cognate CD4+ T cell help. J Exp Med 186:65-67, 1997

    Google Scholar 

  43. Maecker HT, Umetsu DT, Dekruyff RH, Levy S: Cytotoxic T cell responses to DNA vaccination: Dependence on antigen presentation via class II MHC. J Immunol 161:6532-6536, 1998

    Google Scholar 

  44. Oka Y, Udaka K, Tsuboi A, Elisseeva OA, Ogawa H, Aozasa K, Kishimoto T, Sugiyama H: Cancer immunotherapy targeting Wilms' tumor gene WT1 product. J Immunol 164:1873-1880, 2000

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Molecular Medicine, Osaka University Medical School, 2-2, Yamada-Oka, Suita City, Osaka, 565-0871, Japan

    Akihiro Tsuboi, Yoshihiro Oka, Hiroyasu Ogawa & Olga A. Elisseeva

  2. Department of Clinical Laboratory Science, Osaka Medical School, 2-2, Yamada-Oka, Suita City, Osaka, 565-0871, Japan

    Hanfen Li, Kotomi Kawasaki & Haruo Sugiyama

  3. Department of Pathology, Osaka Medical School, 2-2, Yamada-Oka, Suita City, Osaka, 565-0871, Japan

    Katsuyuki Aozasa

  4. Osaka University, 1-1, Yamada-Oka, Suita City, Osaka, 565-0871, Japan

    Tadamitsu Kishimoto

  5. PREST, JST, and Department of Biophysics, Kyoto University, Sakyo, Kyoto, Japan

    Keiko Udaka

Authors
  1. Akihiro Tsuboi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yoshihiro Oka
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Hiroyasu Ogawa
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Olga A. Elisseeva
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Hanfen Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Kotomi Kawasaki
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Katsuyuki Aozasa
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Tadamitsu Kishimoto
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Keiko Udaka
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Haruo Sugiyama
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tsuboi, A., Oka, Y., Ogawa, H. et al. Cytotoxic T-Lymphocyte Responses Elicited to Wilms' Tumor Gene WT1 Product by DNA Vaccination. J Clin Immunol 20, 195–202 (2000). https://doi.org/10.1023/A:1006637529995

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1006637529995

Search

Navigation